Sarepta to seek early FDA approval for gene therapy to treat Duchenne muscular dystrophy

Retrieved on: 2022-07-29 19:10:32

Tags for this article:

Click the tags to see associated articles and topics

Sarepta to seek early FDA approval for gene therapy to treat Duchenne muscular dystrophy. View article details on hiswai:

Excerpt

A troubling report on Cerner's VA rollout offers a rare look into the hidden harms of health records. By Katie Palmer · Health Tech ...

Article found on: www.statnews.com